Compare Visa Inc (V) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Visa Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? Visa Inc trades at $395.33 (market cap $743.55B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Visa Inc is far larger — about 413.1× Vir Biotechnology Inc. Common Stock's market cap, and Visa Inc pays a 0.68% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Visa Inc for 115 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| V | VIR | |
|---|---|---|
Market Cap | $743.55B | $1.80B |
Volume | 7,478,804 | 1,782,836 |
Sector | Financials | Health |
52-Week High | $396.06 | $11.78 |
52-Week Low | $295.52 | $5.12 |
Typical Hold Time | 115 Days | 0 Days |
Enterprise Value | $754.13B | $1.36B |
Dividend Yield | 0.68% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Visa (V) trades at $396.06, up 1.74% today, near its 52-week high. The stock shows strong technical momentum with bullish moving averages and key resistance at $399. Fundamentally, Visa reported robust earnings beats in recent quarters, with Q2 2026 results due April 28. Revenue grew to $40B in 2025, with a net income margin of 50.78%, though the P/E ratio of 33.71 is elevated. Recent news highlights Visa's push into AI-driven commerce and stablecoin partnerships.
Outlook remains positive with 85% analyst buy ratings and a $423.29 consensus target, implying 7% upside. Risks include competitive fintech threats and regulatory scrutiny. Strong cash flow and institutional accumulation support long-term growth, but high valuation requires sustained execution.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Visa Inc
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
